Robinson Julius
Known title: DirectorCIK: 0001909375
Associated companies
Transaction History
| BJRI | ▲ Buy | Grant | 2,955 | $0 | 6/18/2026 | View on chart |
| BJRI | ▲ Buy | Grant | 2,747 | $125K | 6/19/2025 | View on chart |
| BJRI | ▲ Buy | Grant | 1,824 | $63K | 1/15/2025 | View on chart |
| BJRI | ▲ Buy | Grant | 219 | $8K | 1/15/2025 | View on chart |
| BJRI | ▲ Buy | Grant | 3,453 | $110K | 1/15/2024 | View on chart |
| BJRI | ▲ Buy | Grant | 3,510 | $110K | 1/15/2023 | View on chart |
| BJRI | ▲ Buy | Grant | 3,130 | $110K | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
BJRI Faces Mixed Valuation Views on Growth and Cash Flow
Analysts are split on BJRI’s value. One view suggests the stock could be 21% undervalued because of new unit growth, while another view sees it as 12% overvalued based on current cash flow. The market appears to be finally acknowledging BJRI’s growth story, as noted in recent commentary. These contrasting assessments reflect the broader debate among investors about the company’s future prospects.
BJRI Faces Mixed Valuation Views on Growth and Cash Flow. Analysts are split on BJRI’s value. One view suggests the stock could be 21% undervalued because of new unit growth, while another view sees it as 12% overvalued based on current cash flow. The market appears to be finally acknowledging BJRI’s growth story, as noted in recent commentary. These contrasting assessments reflect the broader debate among investors about the company’s future prospects.